Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Yichang Hec Changjiang Pharm
1558YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. The company's products are Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It has a strategic cooperation framework agreement with Jointown Pharmaceutical Group Co., Ltd., as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. Address: No. 38, Binjiang Road, Yichang, China
Analytics
Objectif de Cours de WallStreet
120.27 HKDRatio C/B
4.3971Rendement du dividende
–Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés 1558
Analyse des dividendes 1558
Croissance des dividendes sur 5 ans
–Croissance continue
–Ratio de distribution Moyenne sur 5 ans
44 %Historique des dividendes 1558
Valorisation des titres 1558
financières 1558
Résultats | 2019 | Dynamique |